JamilaRida1*,HoudaMoubachir1,YoussefBouchriti2

目的：哮喘是一个严重的公共卫生问题。本研究旨在确定阿加迪尔，苏斯——马萨地区医院中心(SMRHC)报告的哮喘病例的特征。2019年在SMRHC的肺科和儿科进行了回顾性分析。作为数据支持，使用了报告记录和数据收集⼯作表。今年报告了141例。最高频率出现在2月(21.9%)和4月(26.6%)。男性和女性都受到影响(性别比男性/女性=0.98)。哮喘患者的平均年龄为40.7±25.1岁。大多数病例来自在SMRHC就诊方便的地区。为了获得更准确的知识并为研究做出贡献，应就该主题进行相关研究。我们希望，我们的研究结果将作为未来研究的基础，以根据WHO和GINA指南改进病例登记系统(数字支持)和升级患者数据。

哮喘;流行病学;控制;监视

[1]AitKhaled,N.,Odhiambo,J.,Pearce,N.,Adjoh,K.S.,Maesano,I.A.,Benhabyles,B.,Bouhayad,Z.,Bahati,E.,Camara,L.,Catteau,C.,ElSony,A.,Esamai,F.O.,Hypolite,I.E.,Melaku,K.,Musa,O.A.,Ng’ang’a,L.,Onadeko,B.O.,Saad,O.,Jerray,M.,…Zar,H.J.(2007).Prevalenceofsymptomsofasthma,rhinitis,andeczemain13-to14-year-oldchildreninAfrica:TheInternationalStudyofAsthmaandAllergiesinChildhoodPhaseIII:ISAACPhaseIIIinAfrica.Allergy,62(3),247–258. [2]AlaouiYazidi,A.,&Bartal,M.(2000).PrevalenceofsensitizationtoolivepollendeterminedbyskinpricktestinMorocco.Amulticentricstudy.[InFrench].RevueFrançaised’Allergologieetd’ImmunologieClinique,40(4),481–488. [3]Asher,M.I.,Montefort,S.,Björkstén,B.,Lai,C.K.,Strachan,D.P.,Weiland,S.K.,&Williams,H.(2006).Worldwidetimetrendsintheprevalenceofsymptomsofasthma,allergicrhinoconjunctivitis,andeczemainchildhood:ISAACPhasesOneandThreerepeatmulticountrycross-sectionalsurveys.TheLancet,368(9537),733–743. [4]Beasley,R.(1998).Worldwidevariationintheprevalenceofsymptomsofasthma,allergicrhinoconjunctivitis,andatopiceczema:ISAAC.TheLancet,351(9111),1225–1232. [5]Benjelloun,A.,AitNasser,K.,Janah,H.,Benchanna,R.,&Bouchentouf,R.(2021).ParticularityofasthmaticpatientsintheSahara:ExampleoftheGuelmimOuedNounregion,Morocco.[InFrench].RevueFrançaised’Allergologie,61(3),177–183. [6]Bouayad,Z.,Aichane,A.,Afif,A.,Benouhoud,N.,Trombati,N.,Chan-Yeung,M.,&Aït-Khaled,N.(2006).PrevalenceandtrendofselfreportedasthmaandotherallergicdiseasesymptomsinMorocco:ISAACphaseIandIII.TheInternationalJournalofTuberculosisandLungDisease:TheOfficialJournaloftheInternationalUnionAgainstTuberculosisandLungDisease,10(4),371–377 [7]Bouchriti,Y.,Elghazali,O.,Kharbach,A.,Gougueni,H.,Haddou,M.A.,&Achbani,A.(2021).CharacteristicsofPatientswithAsthmaandAsthmaControl:ARetrospectiveAnalysisofReportedDatafromPrimaryHealthcareCentersinAgadircity,Morocco(2013-2019).JournalofClinicalandExperimentalInvestigations,12(2),em00766. [8]Carvajal-Urueña,I.,García-Marcos,L.,Busquets-Monge,R.,MoralesSuárez-Varela,M.,GarcíadeAndoin,N.,Batlles-Garrido,J.,BlancoQuirós,A.,López-Silvarrey,A.,García-Hernández,G.,Guillén-Grima,F.,González-Díaz,C.,&Bellido-Blasco,J.(2005).GeographicVariationinthePrevalenceofAsthmaSymptomsinSpanishChildrenandAdolescents.InternationalStudyofAsthmaandAllergiesinChildhood(ISAAC)Phase3,Spain.ArchivosdeBronconeumología((EnglishEdition)),41(12),659–666. [9]CDC.(2016).DeanAG,ArnerTG,SunkiGG,FriedmanR,LantingaM,SangamS,ZubietaJC,SullivanKM,BrendelKA,GaoZ,FontaineN,ShuM,FullerG,SmithDC,NitschkeDA,andFaganRF.EpiInfoTM,adatabaseandstatisticsprogramforpublichealthprofessionals.CDC,Atlanta,GA,USA,2011.(7.2)[Computersoftware]. [10]Chaulet,P.(1989).AsthmaandChronicBronchitisinAfrica:EvidencefromEpidemiologicStudies.Chest,96(3,Supplement),334S-339S. [11]D’Amato,G.,Chong‐Neto,H.J.,MongeOrtega,O.P.,Vitale,C.,Ansotegui,I.,Rosario,N.,Haahtela,T.,Galan,C.,Pawankar,R.,Murrieta‐Aguttes,M.,Cecchi,L.,Bergmann,C.,Ridolo,E.,Ramon,G.,GonzalezDiaz,S.,D’Amato,M.,&Annesi‐Maesano,I.(2020).Theeffectsofclimatechangeonrespiratoryallergyandasthmainducedbypollenandmoldallergens.Allergy,75(9),2219–2228. [12]Douwes,J.,&Pearce,N.(2002).Asthmaandthewesternization‘package.’InternationalJournalofEpidemiology,31(6),1098–1102. [13]ElFadili,S.,Batahar,S.A.,Sajiai,H.,Serhane,H.,&Amro,L.(2016).Évaluationducontrôled’asthmeàMarrakech.RevueFrançaised’Allergologie,56(3),323. [14]ElFtouh,M.,Yassine,N.,Benkheder,A.,Bouacha,H.,Nafti,S.,Taright,S.,Fakhfakh,H.,Ali-Khoudja,M.,Texier,N.,&ElHasnaoui,A.(2009).PaediatricasthmainNorthAfrica:TheAsthmaInsightsandRealityintheMaghreb(AIRMAG)study.RespiratoryMedicine,103,S21–S29. [15]GINA.(2021).GlobalInitiativeforAsthma.GlobalStrategyforAsthmaManagementandPrevention,2021.Availablefrom:www.ginasthma.org [16]Ketfi,A.,Benchia,S.,Khaldi,F.,&Gharnaout,M.(2018).Contrôledel’asthmeenconsultationsspécialisées.RevuedesMaladiesRespiratoires,35,A82. [17]Lake,I.R.,Jones,N.R.,Agnew,M.,Goodess,C.M.,Giorgi,F.,Hamaoui-Laguel,L.,Semenov,M.A.,Solomon,F.,Storkey,J.,Vautard,R.,&Epstein,M.M.(2017).ClimateChangeandFuturePollenAllergyinEurope.EnvironmentalHealthPerspectives,125(3),385–391. [18]Masoli,M.,Fabian,D.,Holt,S.,Beasley,R.,&GlobalInitiativeforAsthma(GINA)Program.(2004).Theglobalburdenofasthma:ExecutivesummaryoftheGINADisseminationCommitteeReport.Allergy,59(5),469–478. [19]Michaels,R.A.(2017).EnvironmentalMoisture,Molds,andAsthma—EmergingFungalRisksintheContextofClimateChange.EnvironmentalClaimsJournal,29(3),171–193. [20]Nafti,S.,Taright,S.,ElFtouh,M.,Yassine,N.,Benkheder,A.,Bouacha,H.,Fakhfakh,H.,Ali-Khoudja,M.,Texier,N.,&ElHasnaoui,A.(2009).PrevalenceofasthmainNorthAfrica:TheAsthmaInsightsandRealityintheMaghreb(AIRMAG)study.RespiratoryMedicine,103,S2–S11. [21]Nejjari,R.,Elaissaoui,Y.,Tebaa,A.,&Rachida,S.(2019).5PSQ-091AsthmaintheMoroccanpopulation.Section5:PatientSafetyandQualityAssurance,A243.2-A243. [22]Pearce,N.,Aït-Khaled,N. [23]Sadeq,M.,Abouqal,R.,&ElMarnissi,A.(2015).Seculartrendsinconsultationsforasthmainearlychildhood,the16administrativeregionsofMorocco,2004–2012.BMCPublicHealth,15(1),905. [24]Urrutia,I.,Aguirre,U.,Sunyer,J.,Plana,E.,Muniozguren,N.,Martínez-Moratalla,J.,Payo,F.,Maldonado,J.A.,&Anto,J.M.(2007).ChangesinthePrevalenceofAsthmaintheSpanishCohortoftheEuropeanCommunityRespiratoryHealthSurvey(ECRHS-II).ArchivosdeBronconeumología((EnglishEdition)),43(8),425–430. [25]Vos,T.,Lim,S.S.,Abbafati,C.,Abbas,K.M.,Abbasi,M.,Abbasifard,M.,Abbasi-Kangevari,M.,Abbastabar,H.,Abd-Allah,F.,Abdelalim,A.,Abdollahi,M.,Abdollahpour,I.,Abolhassani,H.,Aboyans,V.,Abrams,E.M.,Abreu,L.G.,Abrigo,M.R.M.,Abu-Raddad,L.J.,Abushouk,A.I.,…Murray,C.J.L.(2020).Globalburdenof369diseasesandinjuriesin204countriesandterritories,1990–2019:AsystematicanalysisfortheGlobalBurdenofDiseaseStudy2019.TheLancet,396(10258),1204–1222. [26]WHO.(2021,May3).Asthma,Keyfacts.WHO. [27]Yan,D.-C.,Ou,L.-S.,Tsai,T.-L.,Wu,W.-F.,&Huang,J.-L.(2005).Prevalenceandseverityofsymptomsofasthma,rhinitis,andeczemain13-to14-year-oldchildreninTaipei,Taiwan.AnnalsofAllergy,Asthma&Immunology,95(6),579–585.,Beasley,R.,Mallol,J.,Keil,U.,Mitchell,E.,&Robertson,C.(2007).Worldwidetrendsintheprevalenceofasthmasymptoms:PhaseIIIoftheInternationalStudyofAsthmaandAllergiesinChildhood(ISAAC).Thorax,62(9),758–766.

点击下载PDF